Shree Ganesh Remedies share news and announcements
NSE: SGRLBSE: 540737Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹654.85.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹805 Cr1,715th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 12 Aug 2026
- 52.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 15 May 2026
- 4.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- 10.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- 10.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 15 May 2026
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 13,24059.0% delivered
Shree Ganesh Remedies share news and announcements
459 announcements, routine notices left out, newest first. Page 3 of 10.
Aug 2024
12 Aug · Board meeting
5 Aug · Board meeting
Meeting on 12 Aug 2024: quarterly results
Jun 2024
29 Jun · Business
3 Jun · Business
1 Jun · Statement Of Utilization Of Funds
1 Jun · Board meeting
May 2024
31 May · Board meeting
Meeting on 1 Jun 2024: audited results30 May · Board meeting
22 May · Board meeting
Meeting on 30 May 2024: audited results10 May · Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015, Regarding Commencement Of Commercial Production
Apr 2024
17 Apr · Commencement Of Trial Run.
Mar 2024
16 Mar · Board meeting
15 Mar · Management
15 Mar · Board meeting
4 Mar · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Feb 2024
12 Feb · Business
12 Feb · Board meeting
8 Feb · Board meeting
Meeting on 8 Feb 20248 Feb · Board meeting
7 Feb · Board meeting
Meeting on 7 Feb 20247 Feb · Board meeting
5 Feb · Board meeting
Meeting on 12 Feb 2024: quarterly results2 Feb · Board meeting
Meeting on 2 Feb 20242 Feb · Board meeting
Jan 2024
25 Jan · Board meeting
19 Jan · Board meeting
Meeting on 25 Jan 2024: rights issue
Dec 2023
Nov 2023
10 Nov · Business
10 Nov · Board meeting
1 Nov · Board meeting
Meeting on 10 Nov 2023: quarterly results